BICLUSTER_ID : DNREG-590
PATHOGENS /4/ : staphylococcus aureus,streptococcus pneumoniae,helicobacter pylori,burkholderia pseudomallei
TARGETS /6/ : NDUFV2, GMPR2, BLVRA, IDH1, FADS1, NDUFA8
Gene Set | Leading Edge Genes |
---|---|
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | SET, RPS25, CETN2, ILF2, CHPT1, NRAS, GNPAT, MRPL40, MAPRE1, BLVRA, CCNA2, NDUFA8, THAP11, GMNN, WRB, MSH6, PDIA6, IDH1, GOLPH3L, COPB2, SURF1, TFG, ASPM |
NUYTTEN EZH2 TARGETS DN | KIF20A, SET, NDUFV2, ORMDL2, GMPR2, TMPO, PRPS2, CCNB1, GLT8D1, CENPA, MRPS33, DDHD2, GNPAT, CMAS, TMEM48, SYPL1, CCNA2, CENPF, CDCA3, CENPJ, RACGAP1, GMNN, PIGP, FIBP, TPX2, FADS1, TSN, TACC3, ASPM |
FINETTI BREAST CANCER BASAL VS LUMINAL | |
FINETTI BREAST CANCER KINOME RED | |
KAAB FAILED HEART ATRIUM DN | |
REACTOME CELL CYCLE MITOTIC | |
BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | |
LEE LIVER CANCER SURVIVAL DN | |
BORCZUK MALIGNANT MESOTHELIOMA UP | |
NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A | |
BENPORATH CYCLING GENES | |
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP | |
CAIRO HEPATOBLASTOMA UP | |
ODONNELL TARGETS OF MYC AND TFRC DN | |
NCI PLK1 PATHWAY |
Color legend | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
q-value | -1 | -0.2 | -0.05 | -0.01 | -0.001 | -0.0001 | |||||
Color |
helicobacter pylori kx2 npgec | burkholderia pseudomallei | staphylococcus aureus | helicobacter pylori kx2 mgep | streptococcus pneumoniae d39 | helicobacter pylori kx1 npgec | GeneSet Name |
---|---|---|---|---|---|---|
-0.00489 | -0.00532 | -0.00628 | -0.06916 | -0.03975 | -0.00733 | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
-0.01414 | -0.00050 | -0.01504 | -0.08461 | -0.01919 | -0.00564 | NUYTTEN_EZH2_TARGETS_DN |
-0.03351 | -0.00016 | -0.11750 | -0.08225 | -0.06359 | -0.07930 | FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL |
-0.02908 | -0.00049 | -0.08255 | -0.08048 | -0.05476 | -0.07132 | FINETTI_BREAST_CANCER_KINOME_RED |
-0.00202 | -0.02589 | -0.00183 | -0.16688 | -0.05486 | -0.00239 | KAAB_FAILED_HEART_ATRIUM_DN |
-0.00105 | -0.00064 | -0.01121 | -0.13703 | -0.03832 | -0.00054 | REACTOME_CELL_CYCLE_MITOTIC |
-0.00546 | -0.00001 | -0.00471 | -0.07568 | -0.08622 | -0.00339 | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN |
-0.00657 | -0.00069 | -0.00026 | -0.06341 | -0.07780 | -0.00959 | LEE_LIVER_CANCER_SURVIVAL_DN |
-0.00017 | -0.00016 | -0.00005 | -0.04124 | -0.01909 | -0.00038 | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
-0.01433 | -0.01053 | -0.10861 | -0.05605 | -0.12634 | -0.01507 | NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A |
-0.02705 | -0.00026 | -0.03303 | -0.16095 | -0.00237 | -0.01003 | BENPORATH_CYCLING_GENES |
-0.04603 | -0.01642 | -0.11278 | -0.08659 | -0.15969 | -0.03512 | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP |
-0.00788 | -0.08891 | -0.04304 | -0.01330 | -0.02205 | -0.00296 | CAIRO_HEPATOBLASTOMA_UP |
-0.08707 | -0.00005 | -0.19943 | -0.07147 | -0.12637 | -0.02871 | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN |
-0.00213 | -0.00005 | -0.11266 | -0.10251 | -0.02081 | -0.01899 | NCI_PLK1_PATHWAY |